4.5 Article

RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors

Related references

Note: Only part of the references are listed.
Article Oncology

Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition

Tomoo Daifu et al.

Summary: Malignant rhabdoid tumor (MRT) is a rare and highly aggressive pediatric malignancy with poor prognosis. Current therapies are not effective enough, making the inhibition of RUNX1 a potential novel strategy for MRT treatment.

PEDIATRIC BLOOD & CANCER (2021)

Article Multidisciplinary Sciences

Inhibition of MYC by the SMARCB1 tumor suppressor

April M. Weissmiller et al.

NATURE COMMUNICATIONS (2019)

Article Medicine, Research & Experimental

Genetic regulation of the RUNX transcription factor family has antitumor effects

Ken Morita et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Multidisciplinary Sciences

Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells

Ken Morita et al.

SCIENTIFIC REPORTS (2017)

Review Hematology

Role of RUNX1 in hematological malignancies

Raman Sood et al.

BLOOD (2017)

Review Oncology

The RUNX family: developmental regulators in cancer

Yoshiaki Ito et al.

NATURE REVIEWS CANCER (2015)

Article Medicine, Research & Experimental

Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells

Susumu Goyama et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Oncology

Extracranial rhabdoid tumours: what we have learned so far and future directions

Bernadette Brennan et al.

LANCET ONCOLOGY (2013)

Article Cell Biology

Addiction of t(8;21) and inv(16) Acute Myeloid Leukemia to Native RUNX1

Oren Ben-Ami et al.

CELL REPORTS (2013)

Article Biochemistry & Molecular Biology

Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression

Yoshiki Katsumi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Article Cell Biology

RUNX1 and its understudied role in breast cancer

Kevin A. Janes

CELL CYCLE (2011)

Article Gastroenterology & Hepatology

Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial Cells

Ti Ling Chang et al.

GASTROENTEROLOGY (2010)

Article Cell Biology

The Human SWI/SNF Complex Associates With RUNX1 to Control Transcription of Hematopoietic Target Genes

Rachit Bakshi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2010)

Article Medicine, Research & Experimental

Runx2 regulates survivin expression in prostate cancer cells

Minyoung Lim et al.

LABORATORY INVESTIGATION (2010)

Review Chemistry, Multidisciplinary

Synthesis and biological properties of sequence-specific DNA-alkylating pyrrole-imidazole polyamides

Toshikazu Bando et al.

ACCOUNTS OF CHEMICAL RESEARCH (2006)

Letter Oncology

Where to next with extracranial rhabdoid tumours in children

BMD Brennan et al.

EUROPEAN JOURNAL OF CANCER (2004)

Article Biochemistry & Molecular Biology

Livin, a novel inhibitor of apoptosis protein family member

GM Kasof et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)